Life quality, anxiety and depression in patients with сhronic obstructive pulmonary disease (literature review)

O. Shevchenko, V. Kiba, V. Petrenko, L. Todoriko, O. Pohorielova
{"title":"Life quality, anxiety and depression in patients with сhronic obstructive pulmonary disease (literature review)","authors":"O. Shevchenko, V. Kiba, V. Petrenko, L. Todoriko, O. Pohorielova","doi":"10.30978/tb-2022-2-41","DOIUrl":null,"url":null,"abstract":"Chronic obstructive pulmonary disease (COPD) is an irreversible disease, the main symptoms of which are shortness of breath and cough. With progression, these symptoms worsen the patients’ life quality, limit their physical activity and lead to psychological problems. COPD is the fourth most common disease in the world and one of the leading causes of death. A review of epidemiological studies shows that depression occurs in patients with COPD in 6—80 % of cases, with an average of about 40 %. Also, these patients often have anxiety disorders in 10 to 55 % of cases.158 literature sources in Pubmed database on request COPD AND depression AND anxiety for last 10 years were included to the study and 44 of them were selected for further detailed study.According to the analysis of literature sources, possible relationships between COPD, life quality, anxiety and depressive disorders were found, approaches to their detection, monitoring and treatment were described, as well as the importance of controlling COPD symptoms to improve the patients’ life quality and reduce the manifestations of psychological and mental disorders. Evidence has been found indicating that an increase in physical activity when COPD symptoms are controlled changes the state of functioning of central monoamines, increases the regulation of the hypothalamic­-pituitary-­adrenal system, increases the release of endogenous opioids and decreases the severity of systemic inflammation, which reduces the manifestations of anxiety and depression.Due to the bidirectional relationship of patients’ life quality, depression and anxiety, and COPD, the most effective is an integrated approach that improves the patient’s condition through the impact on both physical and psychological factors. However, there is still a need for randomized trials to definitively study the benefits of psychological, pharmacological, and combined treatments for depression and anxiety disorders in COPD.","PeriodicalId":292478,"journal":{"name":"Tuberculosis, Lung Diseases, HIV Infection","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberculosis, Lung Diseases, HIV Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30978/tb-2022-2-41","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic obstructive pulmonary disease (COPD) is an irreversible disease, the main symptoms of which are shortness of breath and cough. With progression, these symptoms worsen the patients’ life quality, limit their physical activity and lead to psychological problems. COPD is the fourth most common disease in the world and one of the leading causes of death. A review of epidemiological studies shows that depression occurs in patients with COPD in 6—80 % of cases, with an average of about 40 %. Also, these patients often have anxiety disorders in 10 to 55 % of cases.158 literature sources in Pubmed database on request COPD AND depression AND anxiety for last 10 years were included to the study and 44 of them were selected for further detailed study.According to the analysis of literature sources, possible relationships between COPD, life quality, anxiety and depressive disorders were found, approaches to their detection, monitoring and treatment were described, as well as the importance of controlling COPD symptoms to improve the patients’ life quality and reduce the manifestations of psychological and mental disorders. Evidence has been found indicating that an increase in physical activity when COPD symptoms are controlled changes the state of functioning of central monoamines, increases the regulation of the hypothalamic­-pituitary-­adrenal system, increases the release of endogenous opioids and decreases the severity of systemic inflammation, which reduces the manifestations of anxiety and depression.Due to the bidirectional relationship of patients’ life quality, depression and anxiety, and COPD, the most effective is an integrated approach that improves the patient’s condition through the impact on both physical and psychological factors. However, there is still a need for randomized trials to definitively study the benefits of psychological, pharmacological, and combined treatments for depression and anxiety disorders in COPD.
慢性阻塞性肺疾病患者的生活质量、焦虑和抑郁(文献综述)
慢性阻塞性肺疾病(COPD)是一种不可逆转的疾病,其主要症状是呼吸短促和咳嗽。随着病情的发展,这些症状恶化了患者的生活质量,限制了他们的身体活动,并导致心理问题。慢性阻塞性肺病是世界上第四大常见疾病,也是导致死亡的主要原因之一。对流行病学研究的回顾表明,6 - 80%的COPD患者出现抑郁,平均约为40%。此外,这些患者通常在10%到55%的病例中患有焦虑症。本研究纳入了Pubmed数据库中近10年的158篇COPD和抑郁、焦虑文献,并从中选择44篇文献进行进一步的详细研究。通过文献来源分析,发现COPD与生活质量、焦虑、抑郁障碍之间可能存在的关系,阐述其检测、监测和治疗方法,以及控制COPD症状对改善患者生活质量、减少心理和精神障碍表现的重要性。已有证据表明,在COPD症状得到控制时,增加体力活动可改变中枢单胺的功能状态,增加下丘脑-垂体-肾上腺系统的调节,增加内源性阿片类物质的释放,降低全身炎症的严重程度,从而减少焦虑和抑郁的表现。由于患者的生活质量、抑郁和焦虑与COPD存在双向关系,因此最有效的是通过对生理和心理因素的影响来改善患者病情的综合方法。然而,仍然需要随机试验来明确研究心理、药物和联合治疗COPD患者抑郁和焦虑障碍的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信